about
Intravenous self-administration of entactogen-class stimulants in male ratsDifferential muscarinic and NMDA contributions to visuo-spatial paired-associate learning in rhesus monkeysChronic periadolescent alcohol consumption produces persistent cognitive deficits in rhesus macaquesChronic alcohol consumption impairs visuo-spatial associative memory in periadolescent rhesus monkeys.Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats.Oral administration of (+/-)3,4-methylenedioxymethamphetamine and (+)methamphetamine alters temperature and activity in rhesus macaques.Differential contributions of dopaminergic D1- and D2-like receptors to cognitive function in rhesus monkeys.Neuroimmunity, drugs of abuse, and neuroAIDS.Active vaccination attenuates the psychostimulant effects of α-PVP and MDPV in rats.Locomotor Stimulant and Rewarding Effects of Inhaling Methamphetamine, MDPV, and Mephedrone via Electronic Cigarette-Type Technology.Inhaled delivery of Δ(9)-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology.Ketamine impairs multiple cognitive domains in rhesus monkeys.Chronic alcohol consumption generates a vulnerable immune environment during early SIV infection in rhesus macaques.High ambient temperature facilitates the acquisition of 3,4-methylenedioxymethamphetamine (MDMA) self-administration.Locomotor and reinforcing effects of pentedrone, pentylone and methylone in rats.Effective active vaccination against methamphetamine in female rats.Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol.Compulsive-Like Sufentanil Vapor Self-Administration in Rats.Effects of parametric feeding manipulations on behavioral performance in macaques.Scopolamine alters rhesus monkey performance on a novel neuropsychological test battery.Effects of Δ9-THC and cannabidiol vapor inhalation in male and female ratsBinge-like acquisition of α-pyrrolidinopentiophenone (α-PVP) self-administration in female ratsTolerance to hypothermic and antinoceptive effects of ∆9-tetrahydrocannabinol (THC) vapor inhalation in ratsEffects of Δ⁹-tetrahydrocannabinol (THC) vapor inhalation in Sprague-Dawley and Wistar ratsEffects of nicotine and THC vapor inhalation administered by an electronic nicotine delivery system (ENDS) in male ratsLasting effects of repeated ∆9 -tetrahydrocannabinol vapour inhalation during adolescence in male and female ratsΔ9-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions
P50
Q30680394-82E6D9F9-1641-4041-B5E9-D595E49878AEQ33829221-25927062-C79A-4EE8-B0BD-BDF793B9A56DQ34302547-0456A64D-0370-4092-BA24-F57D5CBB5E27Q34507740-7E5D199C-1B4B-4124-ABFA-79504A1AA38CQ35875875-E8C8F5D4-2107-48FC-A70A-9FCA1EB18342Q35989723-DCD27173-FB35-4FBA-BC9E-092B7F35266BQ36176714-792AEBE7-0074-428A-ACED-A40D662A99D5Q37015388-E742074E-0A9C-4ADA-8ABB-6A8AEB6E2AC6Q39107792-5CBC6BBC-413D-4C2D-998F-D2AFA20E3BB4Q39699950-4CA1F259-DBA2-4BEF-B0B0-20DA6CD251BFQ41654668-DD423862-EBE9-46CC-AEF6-F6DE65327126Q42124923-9966A1F4-1D06-4845-AA0F-A262436AE397Q43006607-9D450CB3-FA46-472C-ABD1-DA8793D331EAQ47312691-5EC27030-32DA-452E-908E-55EF5E00ECA7Q47647717-CA943315-8661-4A9F-A128-A03FD8A0B5A0Q47784195-83334AC3-90C4-4C24-8961-79FE7748C794Q47963305-33F433D2-EF6D-4EE0-8638-70446971AA9DQ48232156-0939DB13-BBA1-40FB-9F88-A38698C9E26FQ48551884-76A011F4-C4FE-4B60-9AE3-28311E4D0C77Q52894634-E47CAA18-7054-4FC7-B07C-F7F6D26D8A23Q89122006-4D2F25AD-02AF-48BA-A9D7-C1A63A08461CQ89126816-FD5EF9D6-2014-4EF7-8E58-1B4368522386Q90380074-13937D30-E0DB-4A3F-8ADF-0DC48D3E74F0Q91983148-46789636-E2AC-418E-852E-15CC256A9C2FQ92413232-A3772C06-A499-4F3C-8D75-2FC573E57FD3Q93068820-86F1DBAD-0B48-4E83-A679-BC2EE8817E48Q93070988-A9CD30E2-D25D-4B9A-BFE1-4B17EDDDD5D0
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michael A. Taffe
@ast
Michael A. Taffe
@en
Michael A. Taffe
@es
Michael A. Taffe
@nl
Michael A. Taffe
@sl
type
label
Michael A. Taffe
@ast
Michael A. Taffe
@en
Michael A. Taffe
@es
Michael A. Taffe
@nl
Michael A. Taffe
@sl
prefLabel
Michael A. Taffe
@ast
Michael A. Taffe
@en
Michael A. Taffe
@es
Michael A. Taffe
@nl
Michael A. Taffe
@sl
P106
P1153
6603378605
P21
P31
P496
0000-0001-9827-1738